Novabase SGPS (XLIS:NBA) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XLIS:NBA Novabase SGPS XLIS:NBA
58 GF Score
Price €7.56
GF Value €4.23
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Novabase SGPS Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Novabase SGPS is: Moderate Risk: Sensitive, better choose undervalued stock.

Novabase SGPS  (XLIS:NBA) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Novabase SGPS Risk Assessment Related Terms

XLIS:NBA vs IBM, ACN, FISV: Risk Assessment Comparison

For the Information Technology Services subindustry, Novabase SGPS's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novabase SGPS Risk Assessment vs Software Industry

For the Software industry and Technology sector, Novabase SGPS's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Novabase SGPS's Risk Assessment falls into.


XLIS:NBA
58GF Score
Novabase SGPS XLIS:NBA
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Novabase SGPS (XLIS:NBA) Overvalued in 2026?

Based on GuruFocus' analysis, Novabase SGPS stock appears to be overvalued. The current stock price of €7.56 is trading 78.7% above its estimated GF Value™ of €4.23. GuruFocus considers Novabase SGPS to be Significantly Overvalued.

Key valuation signals for XLIS:NBA:

  • Risk Assessment:
  • GF Value™: €4.23 vs. price of €7.56 (78.7% above fair value)
  • GF Score™: 58/100 with 1 warning sign

No single metric tells the full story. See the XLIS:NBA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novabase SGPS Business Description

Other Exchanges 0MTZ:UKNVQ:Germany
Address Avenida D Joao II, 34, Parque das Nacoes, Lisbon, PRT, 1998-031
Novabase SGPS is engaged in holding and managing financial holdings in other companies. The Group operates through two business areas: Next-Gen (NG), which generates maximum revenue and operates under the Celfocus commercial brand, providing IT consulting and services focused on the Financial Services and Telecommunications industries across Europe and the Middle East; and Value Portfolio (VP), which develops venture capital activities. The Next-Gen and IT Service segment focuses on Design & UX, insights through data, native & scalable cloud, digital architecture, exposure to APIs, AI/Analytics, automation of tests & engineering, continuous delivery, and intelligent operations. The Group operates in Portugal, Europe, the Middle East, and Africa.
58GF Score

Get the complete analysis for XLIS:NBA

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.56
Price
€4.23
GF Value